Understanding GLP-1
US$ 22.51
glp-1 agonists drugs Agonists: A Comprehensive Overview Holding GLP-1 Agonists Prior to
Description
78 The average half-life of exenatide is 2.4 h, 2 to 3 times per day
Contraindications: Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use this drug
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
The weight-lowering effects of GLP-1 RAs are mediated through multiple, interrelated mechanisms
A trial of sugar-free or sugar-sweetened beverages and body weight in children
Future research should prioritize the development of next-generation agonists, explore combination therapies, and integrate precision medicine approaches to optimize patient outcomes
